Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MSN Pharmachem Private Limited, part of the larger MSN Group based in Hyderabad, India, specializes in the research, development, manufacturing, and commercialization of active pharmaceutical ingredients (APIs) and finished dosage forms. The company has a global presence with over $670 million USD turnover in FY2022. It operates more than twenty state-of-the-art facilities across India and the USA. Its portfolio covers over thirty-five therapeutic areas with more than four hundred fifty APIs and three hundred finished dosages. The company holds a leading position globally in US DMF filings for APIs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MSN Pharmachem.